Exploring Patient Experiences in Managing Chronic Illness at Home with Wearable Medical Devices
Main Article Content
Abstract
Wearable medical devices (WMDs) are rapidly transforming chronic care by integrating health technology into patients’ daily lives. While research has emphasized technical performance and clinical outcomes, less attention has been given to users’ personal experiences and interpretations in home-based health monitoring. Despite increased adoption, there remains a limited understanding of the personal meanings users assign to WMDs—raising the question: how do individuals make sense of living with wearable devices in the context of chronic illness? This study uses an interpretative phenomenological approach to explore users’ lived experiences and provide insight into the emotional, cognitive, and social dimensions of device use. Data were collected through in-depth, semi-structured interviews with chronic disease patients using WMDs, and analyzed using Interpretative Phenomenological Analysis (IPA). The results revealed four key themes: the duality of surveillance and support, empowerment through self-monitoring, emotional attachment to technology, and privacy-related concerns. These themes highlight how WMDs are not only functional tools but also deeply embedded in the subjective experience of illness management. The findings enhance our understanding of how digital health technologies reshape user identities, care relationships, and perceptions of autonomy—suggesting the need for more human-centered design and implementation strategies in digital health research.
Article Details
References
Ahmed, Z. (2020). Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis. Human Genomics, 14(1). Scopus. https://doi.org/10.1186/s40246-020-00287-z
Bunnik, E. M., Dondorp, W. J., Bredenoord, A. L., de Wert, G., & Cornel, M. C. (2021). Mainstreaming informed consent for genomic sequencing: A call for action. European Journal of Cancer, 148, 405–410. Scopus. https://doi.org/10.1016/j.ejca.2021.02.029
Cannon, P., Asokan, A., Czechowicz, A., Hammond, P., Kohn, D. B., Lieber, A., Malik, P., Marks, P., Porteus, M., Verhoeyen, E., Weissman, D., Weissman, I., & Kiem, H.-P. (2021). Safe and Effective in Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development. Human Gene Therapy, 32(1–2), 31–42. Scopus. https://doi.org/10.1089/hum.2020.263
Grassi, L., Alfonsi, R., Francescangeli, F., Signore, M., De Angelis, M. L., Addario, A., Costantini, M., Flex, E., Ciolfi, A., Pizzi, S., Bruselles, A., Pallocca, M., Simone, G., Haoui, M., Falchi, M., Milella, M., Sentinelli, S., Di Matteo, P., Stellacci, E., … Bonci, D. (2019). Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases. Cell Death and Disease, 10(3). Scopus. https://doi.org/10.1038/s41419-019-1453-0
Hajj, A., Hachem, R., Khoury, R., Hallit, S., ElJEBBAWI, B., Nasr, F., El Karak, F., Chahine, G., Kattan, J., & Rabbaa Khabbaz, L. (2021). Clinical and genetic factors associated with anxiety and depression in breast cancer patients: A cross-sectional study. BMC Cancer, 21(1). Scopus. https://doi.org/10.1186/s12885-021-08615-9
Ning, P., Chen, Y., Bai, Q., Xu, C., Deng, C., Cheng, Q., & Cheng, Y. (2022). Multimodal Imaging-Guided Spatiotemporal Tracking of Photosensitive Stem Cells for Breast Cancer Treatment. ACS Applied Materials and Interfaces, 14(6), 7551–7564. Scopus. https://doi.org/10.1021/acsami.1c13072
Panes, J., Bouma, G., Ferrante, M., Kucharzik, T., Nachury, M., De La Portilla De Juan, F., Reinisch, W., Selvaggi, F., Tschmelitsch, J., Brett, N. R., Ladouceur, M., Binek, M., Hantsbarger, G., Campbell-Hill, S., Karki, C., & Buskens, C. (2022). INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial. Inflammatory Bowel Diseases, 28(11), 1737–1745. Scopus. https://doi.org/10.1093/ibd/izab361
Satterlee, A. B., Dunn, D. E., Lo, D. C., Khagi, S., & Hingtgen, S. (2019). Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma. Neuro-Oncology, 21(12), 1552–1564. Scopus. https://doi.org/10.1093/neuonc/noz138
Scibetta, A. C., Morris, E. R., Liebowitz, A. B., Gao, X., Lu, A., Philippon, M. J., & Huard, J. (2019). Characterization of the chondrogenic and osteogenic potential of male and female human muscle-derived stem cells: Implication for stem cell therapy. Journal of Orthopaedic Research, 37(6), 1339–1349. Scopus. https://doi.org/10.1002/jor.24231
Sheets, K. T., Ewend, M. G., Mohiti-Asli, M., Tuin, S. A., Loboa, E. G., Aboody, K. S., & Hingtgen, S. D. (2020). Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma. Molecular Therapy, 28(4), 1056–1067. Scopus. https://doi.org/10.1016/j.ymthe.2020.02.008
Shi, M., Li, Y.-Y., Xu, R.-N., Meng, F.-P., Yu, S.-J., Fu, J.-L., Hu, J.-H., Li, J.-X., Wang, L.-F., Jin, L., & Wang, F.-S. (2021). Mesenchymal stem cell therapy in decompensated liver cirrhosis: A long-term follow-up analysis of the randomized controlled clinical trial. Hepatology International, 15(6), 1431–1441. Scopus. https://doi.org/10.1007/s12072-021-10199-2
Shin, K., Koo, K. H., Jeong, J., Park, S. J., Choi, D. J., Ko, Y.-G., & Kwon, H. (2019). Three-Dimensional Culture of Salivary Gland Stem Cell in Orthotropic Decellularized Extracellular Matrix Hydrogels. Tissue Engineering - Part A, 25(19–20), 1396–1403. Scopus. https://doi.org/10.1089/ten.tea.2018.0308
Wang, Y., Ma, X., Chai, W., & Tian, J. (2019). Multiscale stem cell technologies for osteonecrosis of the femoral head. Stem Cells International, 2019. Scopus. https://doi.org/10.1155/2019/8914569
Yang, C., Ni, X., Mao, D., Ren, C., Liu, J., Gao, Y., Ding, D., & Liu, J. (2019). Seeing the fate and mechanism of stem cells in treatment of ionizing radiation-induced injury using highly near-infrared emissive AIE dots. Biomaterials, 188, 107–117. Scopus. https://doi.org/10.1016/j.biomaterials.2018.10.009
Zhu, Y., Smith, D. J., Zhou, Y., Li, Y.-R., Yu, J., Lee, D., Wang, Y.-C., Di Biase, S., Wang, X., Hardoy, C., Ku, J., Tsao, T., Lin, L. J., Pham, A. T., Moon, H., McLaughlin, J., Cheng, D., Hollis, R. P., Campo-Fernandez, B., … Yang, L. (2019). Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer. Cell Stem Cell, 25(4), 542-557.e9. Scopus. https://doi.org/10.1016/j.stem.2019.08.004